1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        South and Central America PCR for Respiratory Infection Diagnostics Market – By Type

1.3.2        South and Central America PCR for Respiratory Infection Diagnostics Market – By Product Type

1.3.3        South and Central America PCR for Respiratory Infection Diagnostics Market – By Infection Type

1.3.4        South and Central America PCR for Respiratory Infection Diagnostics Market – By End User

1.3.5        South and Central America PCR for Respiratory Infection Diagnostics Market– By Country

2.             South and Central America PCR for Respiratory Infection Diagnostics Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             PCR for Respiratory Infection Diagnostics Market– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        South and Central America (SCAM) – PEST Analysis

4.3       Experts Opinion

5.             PCR for Respiratory Infection Diagnostics Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Increasing Burden of Chronic Respiratory Diseases (CRDs)

5.1.2        Growing Developments in PCR Testing

5.2       Market Restraints

5.2.1        Availability of Alternative Assays

5.3       Market Opportunities

5.3.1        Use of PCR Testing for Various Respiratory Infection Diagnostics

5.4       Future Trends

5.4.1        Developments in PCR Technology

5.5       Impact analysis

6.             PCR for Respiratory Infection Diagnostics Market– South and Central America Analysis

6.1       South and Central America PCR for Respiratory Infection Diagnostics Market Revenue Forecast and Analysis

7.             PCR for Respiratory Infection Diagnostics Market Analysis by Type

7.1       Overview

7.2       PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2021 and 2028)

7.3       Real Time PCR (qPCR)

7.3.1        Overview

7.3.2        Real Time PCR (qPCR): PCR for Respiratory Infection Diagnostics market – Revenue and Forecast to 2028 (US$ Million)

7.4       Multiplex PCR

7.4.1        Overview

7.4.2        Multiplex PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5       Traditional PCR

7.5.1        Overview

7.5.2        Traditional PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6       Digital PCR

7.6.1        Overview

7.6.2        Digital PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7       Reverse Transcriptase (RT-PCR)

7.7.1        Overview

7.7.2        Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.8       Others

7.8.1        Overview

7.8.2        Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.             PCR for Respiratory Infection Diagnostics Market Analysis – By Product Type

8.1       Overview

8.2       PCR for Respiratory Infection Diagnostics Market, by Product Type 2021 & 2028 (%)

8.3       Reagents and kits

8.3.1        Overview

8.3.2        Reagents and Kits: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4       Instruments

8.4.1        Overview

8.4.2        Instruments: PCR for respiratory infection diagnostics market – Revenue and Forecast to 2028 (US$ Million)

8.5       Others

8.5.1        Overview

8.5.2        Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.             PCR for Respiratory Infection Diagnostics Market– By Infection Type

9.1       Overview

9.2       PCR for Respiratory Infection Diagnostics Market Revenue Share, by Infection Type, 2021 & 2028 (%)

9.3       Bacterial Infections

9.3.1        Overview

9.3.2        Bacterial Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.3        Bordetella

9.3.3.1      Overview

9.3.3.2      Bordetella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.4        Streptococcus Pneumoniae

9.3.4.1      Overview

9.3.4.2      Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.5        Staphylococcus Aureus

9.3.5.1      Overview

9.3.5.2      Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.6        Haemophilus Influenzae

9.3.6.1      Overview

9.3.6.2      Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.7        Moraxella Catarrhalis

9.3.7.1      Overview

9.3.7.2      Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.8        Mycoplasma Pneumoniae

9.3.8.1      Overview

9.3.8.2      Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.9        Chlamydophila Pneumoniae

9.3.9.1      Overview

9.3.9.2      Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.10     Legionella

9.3.10.1    Overview

9.3.10.2    Legionella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.11     Others

9.3.11.1    Overview

9.3.11.2    Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4       Viral Infection

9.4.1        Overview

9.4.2        Viral Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.3        Rhinoviruses

9.4.3.1      Overview

9.4.3.2      Rhinoviruses: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.4        Influenza Virus

9.4.4.1      Overview

9.4.4.2      Influenza Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.5        Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus

9.4.5.1      Overview

9.4.5.2      Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.6        Respiratory Syncytial Virus (RSV)

9.4.6.1      Overview

9.4.6.2      Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.7        Adenovirus

9.4.7.1      Overview

9.4.7.2      Adenovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.8        Enterovirus

9.4.8.1      Overview

9.4.8.2      Enterovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.9        Parainfluenza

9.4.9.1      Overview

9.4.9.2      Parainfluenza: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.10     Human Metapneumovirus (hMPV)

9.4.10.1    Overview

9.4.10.2    Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.11     Others

9.4.11.1    Overview

9.4.11.2    Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.5       Fungal and Other Pathogens

9.5.1        Overview

9.5.2        Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.          PCR for Respiratory Infection Diagnostics Market– By End User

10.1    Overview

10.2    PCR for Respiratory Infection Diagnostics Market Revenue Share, by End User (2021 and 2028)

10.3    Hospitals

10.3.1     Overview

10.3.2     Hospitals: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.4    Physician Clinics

10.4.1     Overview

10.4.2     Physician Clinics: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5    Clinical Laboratories

10.5.1     Overview

10.5.2     Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.6    Academic and Research Institutions

10.6.1     Overview

10.6.2     Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.7    Biotech and Pharma Companies

10.7.1     Overview

10.7.2     Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.8    Others

10.8.1     Overview

10.8.2     Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

11.          PCR for Respiratory Infection Diagnostics Market – South and Central America Analysis

11.1    South and Central America: PCR for Respiratory Infection Diagnostics Market

11.1.1     Overview

11.1.2     South and Central America: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

11.1.3     South and Central America: PCR for Respiratory Infection Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)

11.1.4     South and Central America: PCR for Respiratory Infection Diagnostics Market, by Product Type- Revenue and Forecast to 2028 (USD Million)

11.1.5     South and Central America: PCR for Respiratory Infection Diagnostics Market, by Infection Type- Revenue and Forecast to 2028 (USD Million)

11.1.5.1    South and Central America: PCR for Respiratory Infection Diagnostics Market, by Viral Infections- Revenue and Forecast to 2028 (USD Million)

11.1.5.2    South and Central America: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections- Revenue and Forecast to 2028 (USD Million)

11.1.6     South and Central America: PCR for Respiratory Infection Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

11.1.7     South and Central America: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)

11.1.7.1    Brazil: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

11.1.7.1.1    Brazil: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

11.1.7.1.2    Brazil: PCR for Respiratory Infection Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)

11.1.7.1.3    Brazil: PCR for Respiratory Infection Diagnostics Market, by Product Type- Revenue and Forecast to 2028 (USD Million)

11.1.7.1.4    Brazil: PCR for Respiratory Infection Diagnostics Market, by Infection Type- Revenue and Forecast to 2028 (USD Million)

11.1.7.1.4.1        Brazil: PCR for Respiratory Infection Diagnostics Market, by Viral Infections- Revenue and Forecast to 2028 (USD Million)

11.1.7.1.4.2        Brazil: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections- Revenue and Forecast to 2028 (USD Million)

11.1.7.1.5    Brazil: PCR for Respiratory Infection Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

11.1.7.2    Argentina: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

11.1.7.2.1    Argentina: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

11.1.7.2.2    Argentina: PCR for Respiratory Infection Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)

11.1.7.2.3    Argentina: PCR for Respiratory Infection Diagnostics Market, by Product Type- Revenue and Forecast to 2028 (USD Million)

11.1.7.2.4    Argentina: PCR for Respiratory Infection Diagnostics Market, by Infection Type- Revenue and Forecast to 2028 (USD Million)

11.1.7.2.4.1        Argentina: PCR for Respiratory Infection Diagnostics Market, by Viral Infections- Revenue and Forecast to 2028 (USD Million)

11.1.7.2.4.2        Argentina: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections- Revenue and Forecast to 2028 (USD Million)

11.1.7.2.5    Argentina: PCR for Respiratory Infection Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

11.1.7.3    Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market- Revenue and Forecast to 2028 (USD Million)

11.1.7.3.1    Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

11.1.7.3.2    Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)

11.1.7.3.3    Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Product Type- Revenue and Forecast to 2028 (USD Million)

11.1.7.3.4    Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Infection Type- Revenue and Forecast to 2028 (USD Million)

11.1.7.3.4.1        Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Viral Infections- Revenue and Forecast to 2028 (USD Million)

11.1.7.3.4.2        Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections- Revenue and Forecast to 2028 (USD Million)

11.1.7.3.5    Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

12.          Impact Of COVID-19 Pandemic on PCR for Respiratory Infection Diagnostics Market

12.1    South and Central America: Impact Assessment of COVID-19 Pandemic

13.          PCR For Respiratory Infection Diagnostics Market–Industry Landscape

13.1    Overview

13.2    Inorganic Growth Strategies

13.2.1     Overview

13.3    Organic Growth Strategies

13.3.1     Overview

14.          Company Profiles

14.1    Abbott

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2    F. HOFFMANN-LA ROCHE LTD.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3    Hologic, Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4    BD

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5    BIO-RAD LABORATORIES INC.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6    bioMerieux SA

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7    QIAGEN

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8    Thermo Fisher Scientific Inc.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9    Seegene Inc

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

15.          Appendix

15.1    About the Insight Partners

15.2    Glossary of Terms

Table 1.             South and Central America PCR for Respiratory Infection Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             South and Central America PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             South and Central America PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             South and Central America PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 5.             South and Central America PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 6.             South and Central America PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             Brazil PCR for Respiratory Infection Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Brazil PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             Brazil PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 10.          Brazil PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 11.          Brazil PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 12.          Brazil PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Argentina PCR for Respiratory Infection Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 14.          Argentina PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Argentina PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 16.          Argentina PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

Table 17.          Argentina PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 18.          Argentina PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25.          Recent Inorganic Growth Strategies in the PCR for Respiratory Infection Diagnostics Market

Table 26.          Recent Organic Growth Strategies in the PCR for Respiratory Infection Diagnostics Market

Table 27.          Glossary of Terms, PCR for Respiratory Infection Diagnostics Market

Figure 1.           PCR for Respiratory Infection Diagnostics Market Segmentation

Figure 2.           PCR for Respiratory Infection Diagnostics Market Segmentation, By Country

Figure 3.           South and Central America PCR for Respiratory Infection Diagnostics Market Overview

Figure 4.           Real-Time PCR (qPCR) Segment Held Largest Share of Type Segment in PCR for Respiratory Infection Diagnostics Market

Figure 5.           South and Central America PCR for Respiratory Infection Diagnostics Market– Leading Country Markets (US$ Million)

Figure 6.           South and Central America (SCAM) PEST Analysis

Figure 7.           PCR for Respiratory Infection Diagnostics Market Impact Analysis of Driver and Restraints

Figure 8.           South and Central America PCR for Respiratory Infection Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2021 and 2028)

Figure 10.        Real Time PCR (qPCR): PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Multiplex PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Traditional PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Digital PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        PCR for Respiratory Infection Diagnostics Market, by Product Type 2021 & 2028 (%)

Figure 17.        Reagents and Kits: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Instruments: PCR for respiratory infection diagnostics market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        PCR for Respiratory Infection Diagnostics Market Share, by Infection Type, 2021 & 2028 (%)

Figure 21.        Bacterial Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 22.        Bordetella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 23.        Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 24.        Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 25.        Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 26.        Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 27.        Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 28.        Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 29.        Legionella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 30.        Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 31.        Viral Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 32.        Rhinoviruses: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 33.        Influenza Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 34.        Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 35.        Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 36.        Adenovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 37.        Enterovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 38.        Parainfluenza: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 39.        Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 40.        Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 41.        Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 42.        PCR for Respiratory Infection Diagnostics Market Share, by End User, 2021 and 2028 (%)

Figure 43.        Hospitals: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 44.        Physician Clinics: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 45.        Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 46.        Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 47.        Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 48.        Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 49.        South and Central America: PCR for Respiratory Infection Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 50.        South and Central America PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 51.        South and Central America: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 52.        Brazil: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 53.        Argentina: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 54.        Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 55.        Impact of COVID-19 Pandemic in South and Central America Country Markets